HCA Healthcare stock holds after earnings-driven valuation reset

HCA Healthcare (US40412C1018) stock reflects a valuation story built on recent results, with Q1 2026 revenue of $18.5 billion and net income of $1.7 billion. The company also reported diluted earnings per share of $6.45 for the same quarter, giving investors a fresh operating baseline.

Q1 2026 sets the tone

Those Q1 2026 figures matter because they place the business on a larger scale than many peers: revenue of $18.5 billion, net income of $1.7 billion, and EPS of $6.45 all point to a highly cash-generative health care operator. In the same period, adjusted EBITDA reached $3.4 billion, which gives the latest quarter a second profit metric beyond net income.

The comparison also helps frame the current setup. Revenue rose from $17.3 billion in Q1 2025 to $18.5 billion in Q1 2026, while net income increased from $1.5 billion to $1.7 billion over the same period.

Margins still matter

For investors, the margin profile remains the key read-through. HCA Healthcare said adjusted EBITDA of $3.4 billion in Q1 2026 came with continued scale across its hospital network, while diluted EPS of $6.45 showed that the quarter translated into strong per-share earnings.

The broader business also benefits from the company size itself. HCA Healthcare operates one of the largest hospital and outpatient platforms in the US, and the latest quarter underscores how that scale converts into earnings even without relying on a single one-off item.

Hospital services carry the load

The core hospital and outpatient services franchise is the main revenue driver, and Q1 2026 showed that it still defines the investment case. Revenue of $18.5 billion was supported by steady operating throughput, while the $1.7 billion net income figure confirmed that the business remained profitable at a large absolute level.

That combination is what market participants usually track most closely in health care providers: top-line growth, absolute earnings, and per-share profitability. Here, all three were present in the latest quarter, and all three moved in the same direction versus Q1 2025.

Revenue up 6.9 percent

The clearest comparison is revenue growth. Q1 2026 revenue of $18.5 billion was up 6.9 percent from $17.3 billion in Q1 2025, and net income rose about 13.3 percent from $1.5 billion to $1.7 billion in the same comparison. EPS of $6.45 and adjusted EBITDA of $3.4 billion added two more period-specific measures to the quarter.

That mix gives HCA Healthcare stock a straightforward fundamental anchor: a larger revenue base, higher net income, and a quarter that remained profitable at scale. The next investor focus is whether that pattern continues in the following reporting periods.

HCA Healthcare services

Hospital services remain the core product set, backed by outpatient care, emergency services, surgery, and other acute-care offerings. In Q1 2026, that mix supported $18.5 billion in revenue and $3.4 billion in adjusted EBITDA, which is the clearest snapshot of how the business translates patient volume into earnings.

HCA Healthcare stock near the quarter

HCA Healthcare stock is best read through the latest quarterly numbers rather than a short-term narrative. The company posted $18.5 billion in revenue, $1.7 billion in net income, and $6.45 in diluted EPS for Q1 2026, all of which define the current operating picture for the shares.